Jim Simons Fate Therapeutics Inc Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 362,619 shares of FATE stock, worth $583,816. This represents 0.0% of its overall portfolio holdings.

Number of Shares

362,619

Previous 548,544 33.89%

Holding current value

$583,816

Previous $1.8 Million 29.46%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$3.12 - $5.57 $580,086 - $1.04 Million	-185,925 Reduced 33.89%	362,619 $1.27 Million
Q2 2024 Aug 09, 2024	BUY	$3.26 - $7.08 $1.79 Million - $3.88 Million	548,544 New	548,544 $1.8 Million
Q3 2023 Nov 14, 2023	SELL	$2.02 - $5.04 $1.14 Million - $2.84 Million	-563,097 Reduced 83.75%	109,219 $232,000
Q2 2023 Aug 11, 2023	SELL	$4.76 - $6.59 $3.14 Million - $4.35 Million	-660,603 Reduced 49.56%	672,316 $3.2 Million
Q1 2023 May 12, 2023	SELL	$4.24 - $11.12 $2 Million - $5.25 Million	-472,017 Reduced 26.15%	1,332,919 $7.6 Million
Q4 2022 Feb 13, 2023	BUY	$9.86 - $23.83 $12.5 Million - $30.2 Million	1,267,417 Added 235.79%	1,804,936 $18.2 Million
Q3 2022 Nov 14, 2022	BUY	$21.04 - $36.06 $11.3 Million - $19.4 Million	537,519 New	537,519 $12 Million
Q2 2022 Aug 12, 2022	SELL	$17.78 - $42.39 $805,771 - $1.92 Million	-45,319 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$29.67 - $60.28 $1.34 Million - $2.73 Million	45,319 New	45,319 $1.76 Million
Q3 2021 Nov 12, 2021	SELL	$59.27 - $95.73 $2.06 Million - $3.32 Million	-34,719 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$67.25 - $92.52 $2.33 Million - $3.21 Million	34,719 New	34,719 $3.01 Million
Q4 2020 Feb 10, 2021	SELL	$38.09 - $100.95 $1.97 Million - $5.21 Million	-51,619 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$30.41 - $40.5 $1.57 Million - $2.09 Million	51,619 New	51,619 $2.06 Million
Q3 2019 Nov 13, 2019	SELL	$15.47 - $22.5 $182,839 - $265,927	-11,819 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$15.61 - $20.44 $1.06 Million - $1.39 Million	-67,843 Reduced 85.16%	11,819 $240,000
Q1 2019 May 14, 2019	BUY	$13.15 - $18.71 $1.05 Million - $1.49 Million	79,662 New	79,662 $1.4 Million

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $156M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account